ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Bristol-Myers Squibb clinical trials

Also known as BMS.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 2,184 studies whose lead sponsor is Bristol-Myers Squibb or one of 14 companies grouped under it. 156 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.

Our grouping of 15 registry names, not the registry’s. See them and correct one ↓

Compare Bristol-Myers Squibb with Merck and AstraZeneca →

Pipeline: 58 programs

Each counted once: 51 with a study Bristol-Myers Squibb leads registered in the last two years, 7 more from Bristol-Myers Squibb's own pipeline.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)
  • Named by Bristol-Myers Squibb only (no registered study yet; not in the 58)

The 5 of 16 with the most live studies.

Program
navlimetostatPhase 3 · Bristol-Myers Squibb: Phase 2 · 10 live · Lung Neoplasms · primary completion Dec 2026☆ Track
pumitamigPhase 3 · Bristol-Myers Squibb: Phase 3 · 9 live · Carcinoma, Non-Small-Cell Lung · primary completion Mar 2028☆ Track
adagrasibPhase 3 · 7 live · Neoplasm Metastasis · primary completion Feb 2028☆ Track
golcadomidePhase 3 · Bristol-Myers Squibb: Phase 3 · 7 live · Lymphoma, Follicular · primary completion Dec 2026☆ Track
zolacabtagene autoleucelPhase 3 · Bristol-Myers Squibb: Phase 3 · 5 live · Scleroderma, Systemic · primary completion Jul 2027☆ Track

11 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Bristol-Myers Squibb’s own registered studies; “Bristol-Myers Squibb says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

3 of Bristol-Myers Squibb’s programs have a dated deal behind them: 1 brought in, 2 developed with a partner. Each from the companies’ own releases and filings, linked; the registry does not record them.

Brought in 1

Developed with a partner 2

What it is testing

The drugs Bristol-Myers Squibb’s studies test, most open studies first — 301 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 301; every drug is on its own page, and each page lists its sponsors.

Coming up

69 of Bristol-Myers Squibb’s studies under way reach primary completion within a year, 13 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 6N’26
  2. 15D
  3. 6J’27
  4. 4F
  5. 7M
  6. 2A
  7. 3M
  8. 6J
  9. 7J
  10. 3A
  11. 3S
  12. 4O
  13. 3N

The 12 nearest

Show 7 more

Add all 69 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 2,184 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1567%Recruiting 140 · Not yet recruiting 16
  • Under way, not recruiting974%
  • Completed1,58072%
  • Stopped early30814%Terminated 237 · Withdrawn 71
  • Status unknown or other432%No longer available 26 · Available 7 · Status unknown 6 · Approved for marketing 4

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 12716
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 6826

By the year each study started; 296 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Bristol-Myers Squibb.

  • Bristol-Myers Squibb
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1,562 studies
  • Celgene
    Acquired — became part of Bristol-Myers Squibb, Nov 20, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    428 studies →
  • Celgene Corporation
    Acquired — became part of Bristol-Myers Squibb, Nov 20, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    52 studies →
  • Mirati Therapeutics Inc.
    Acquired — became part of Bristol-Myers Squibb, Jan 23, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    51 studies →
  • Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Acquired — became part of Bristol-Myers Squibb, Mar 18, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    17 studies →
  • Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
    Acquired — became part of Bristol-Myers Squibb, Nov 20, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    17 studies →
  • Juno Therapeutics, a Subsidiary of Celgene
    Acquired — became part of Bristol-Myers Squibb, Nov 20, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    12 studies →
  • ZymoGenetics
    Acquired — became part of Bristol-Myers Squibb, Oct 12, 2010 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • Turning Point Therapeutics, Inc.
    Acquired — became part of Bristol-Myers Squibb, Aug 17, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • RayzeBio, Inc.
    Acquired — became part of Bristol-Myers Squibb, Feb 26, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • MyoKardia, Inc.
    Acquired — became part of Bristol-Myers Squibb, Nov 17, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • Karuna Therapeutics
    Acquired — became part of Bristol-Myers Squibb, Mar 18, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Adnexus, A Bristol-Myers Squibb R&D Company
    Acquired — became part of Bristol-Myers Squibb, Oct 19, 2007 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Acetylon Pharmaceuticals Incorporated
    Acquired — became part of Bristol-Myers Squibb, Nov 20, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • 2seventy bio
    Acquired — became part of Bristol-Myers Squibb, May 13, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Bristol-Myers Squibb leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 61 areas

Studies

Recruiting first, then most recently updated. Showing 50 of 2,184. Browse all 2,184 →